In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer ...

As a leading provider of health-related education, with almost 6,500 students and approximately 250 academic staff, we offer an extensive portfolio of accredited degree and research programmes ...

The improved engagement with HF patients intended to optimize GDMT was very modest, but did lead to increased use of MRAs.